Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Low Number of Baselines γδ T Cells Increase the Risk of SARS-CoV-2 Post-Vaccination Infection

Version 1 : Received: 16 April 2024 / Approved: 17 April 2024 / Online: 17 April 2024 (08:00:55 CEST)

How to cite: Andreu-Ballester, J.C.; Galindo-Regal, L.; Cuellar, C.; López-Chuliá, F.; García-Ballesteros, C.; Fernández-Muga, L.; Llombart-Cussac, A.; Domínguez-Márquez, M.V. Low Number of Baselines γδ T Cells Increase the Risk of SARS-CoV-2 Post-Vaccination Infection. Preprints 2024, 2024041115. https://doi.org/10.20944/preprints202404.1115.v1 Andreu-Ballester, J.C.; Galindo-Regal, L.; Cuellar, C.; López-Chuliá, F.; García-Ballesteros, C.; Fernández-Muga, L.; Llombart-Cussac, A.; Domínguez-Márquez, M.V. Low Number of Baselines γδ T Cells Increase the Risk of SARS-CoV-2 Post-Vaccination Infection. Preprints 2024, 2024041115. https://doi.org/10.20944/preprints202404.1115.v1

Abstract

Background: The effectiveness of the anti-COVID-19 vaccine remains a matter to be clarified. Methods: The humoral and cellular immunity after the administration of three doses of the Pfizer–BioNTech and Oxford AstraZeneca vaccines against SARS-CoV-2 over one year and the appearance of post-vaccination COVID-19 have been studied. Results: Anti-SARS-CoV-2 IgG and IgA antibodies showed a progressive increase throughout the vaccination period. This increase was greatest after the third dose. The highest levels were observed in subjects who had anti-SARS-CoV-2 antibodies prior to vaccination. There was an increase in CD4+ αβ, CD8+ γδ and TEM CD8+ γδ T cells, and a decrease in apoptosis in CD4+CD8+ and CD56+ αβ and γδ T cells. Post-vaccination SARS-CoV-2 infection was greater than 60%. The symptoms of COVID-19 were very mild and were related to γδ T cell deficit, specifically CD8+ TEMRA and CD56+ γδ TEM, as well as lower pre-vaccine apoptosis levels. Conclusions: Those results demonstrate the important role that γδ T cells play in SARS-CoV-2 vaccine immunization.

Keywords

SARS-CoV-2; vaccine; antibodies; αβ T cells; γδ T cells

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.